Drawing for MUNDIPHARMA

USPTO serial 87536687

MUNDIPHARMA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SEVERSON, JUSTIN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MUNDIPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David S. Safran

David S. Safran ROBERTS MLOTKOWSKI SAFRAN COLE & CALDERON P.C.7918 JONES BRANCH DRIVE, SUITE 500MCLEAN, VA 22102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Douching preparations for personal sanitary or deodorant purposes, toiletries; cosmetics; non-medicated soaps for personal use; Almond soap; Baby hand soap; Bar soap; Bath soaps; Bath soaps in liquid, solid or gel form; Body cream soap; Cakes of soap; Cakes of toilet soap; Cream soaps; Deodorant soap; non-medicated hand soaps; Granulated soaps; non-medicated liquid soap; non-medicated liquid soaps for hands and face; non-medicated liquid soaps for hands, face and body; Loofah soaps; Natural soap bars; Organic soap bars; Paper soaps for personal uses; Perfumed soap; Skin soap; Soap for foot perspiration; Soap powder; non-medicated soaps and detergents; non-medicated soaps for babies; non-medicated soaps for body care; non-medicated soaps for household use; non-medicated soaps for personal use; non-medicated soaps for toilet purposes; Toilet soap; Perfumery; Essential oils; Cosmetics; Hair lotions; Hair care preparations; Non-medicated toiletry preparations; Cosmetics; Cosmetic preparations; Cosmetic preparations for protecting the skin from the sun's rays; Cosmetic sun-protecting preparations; Sun block preparations; Sun screen preparations; Lip balm; Cosmetic sun oils; SPF sun block sprays; Sun block; Sun block preparations; Sun care lotions; Sun creams; Sun screen; Sun-block lotions; Cosmetic sun-tanning preparations; Cosmetic tanning preparations; Self-tanning preparations; Suntan creams; Sun-tanning oils; Sun-tanning oils and lotions; Sun-tanning preparations; Tanning creams; Tanning gels; Tanning milks; Tanning oils; After sun creams; After sun moisturizers; After-sun gels; After-sun lotions; After-sun milks ; After-sun oils; Cosmetic preparations for skin care; Cosmetics sold as an integral component of non-medicated skincare preparations; Anti-aging moisturizer; Anti-aging moisturizers used as cosmetics; Facial moisturizer with SPF; Facial moisturizers; Fragranced facial moisturizer; Skin moisturizer; Skin toners; Non-medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Anti-aging toner; Exfoliant creams; Skin bronzing creams; Oil removing papers for cosmetic purposes; Cosmetic preparations for the hair and scalp; Nail care preparations; Cosmetic preparations for nail drying; Cosmetic preparations for removing gel nails, acrylic nails, and nail polish; Cloths or tissues impregnated with a skin cleanser; Disposable wipes impregnated with cleansing chemicals or compounds for personal hygiene use; Impregnated cleaning pads impregnated with non-medicated toilet preparations; Wipes impregnated with a skin cleanser; Tissues impregnated with cosmetic lotions; Wipes impregnated with a cleaning preparation; Wipes impregnated with a skin cleanserACTIVE—
005Pharmaceutical products for dermatological, ophthalmological, oncological and respiratory use; Analgesics for the treatment of pain; Pharmaceutical preparations for human medicines for the treatment of pain; Pharmaceutical preparations for human medicines for the treatment of neuro-oncological and haematological malignancies; Pharmaceutical preparations for human medicines for the treatment of respiratory diseases; Pharmaceutical preparations for human medicines for the treatment of chronic and progressive auto-immune disease such as rheumatoid arthritis; Pharmaceutical preparations for human medicine for the treatment of minor wounds, cuts, boils, abrasions skin tears and sores, burns, grazes, itching and irritation, rashes; Veterinary preparations for veterinary medicine for the treatment of the treatment of minor wounds, cuts, boils, abrasions skin tears and sores, burns, grazes, itching and irritation, rashes; Veterinary preparations for veterinary medicine for the treatment of pain; Antiseptics and disinfectants for veterinary use; sanitary preparations for medical use; dietetic food and substances adapted for medical or veterinary use; dietary food supplements for humans and animals; medical plasters, medical dressings; disinfectants, antiseptics; preparations and substances for pharmaceutical purposes for the treatment of minor wounds, cuts, boils, abrasions skin tears and sores, burns, grazes, itching and irritation, rashes; pharmaceutical preparations and substances for the treatment of minor wounds, cuts, boils, abrasions skin tears and sores, burns, grazes, itching and irritation, rashes, namely, acids and chemical preparations for pharmaceutical purposes, namely skin creams, gels, oils, lotions and ointments for pharmaceutical purposes, homeopathic pharmaceutical preparations, pharmaceutical preparations being comprised of plant extracts, pharmaceutical preparations for use on the scalp, nails, hair, and skin, and pharmaceutical sunscreen and sun care preparations; antiseptic and antibacterial preparations; wipes, dressings, cloths, and materials for use in dressing wounds, including those impregnated with pharmaceutical preparations; Antibacterial soap; Antibacterial skin soaps; Disinfectant soap; Disinfecting perfumed soap; Medicated soapACTIVE—
042Pharmaceutical research services; pharmaceutical product evaluation; pharmaceutical research and development servicesACTIVE—
044Pharmaceutical services, namely pharmaceutical consultation and advice, pharmaceutical compounding services, pharmacy advice, medical assistanceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 30, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 30, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 9, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 8, 2021EX5GSOU EXTENSION 5 GRANTED—
Feb 8, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 22, 2021EXT5SOU EXTENSION 5 FILED—
Jan 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 25, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 23, 2020EX4GSOU EXTENSION 4 GRANTED—
Jul 23, 2020EXT4SOU EXTENSION 4 FILED—
Jul 23, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 28, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 24, 2020EX3GSOU EXTENSION 3 GRANTED—
Jan 24, 2020EXT3SOU EXTENSION 3 FILED—
Jan 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 23, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 19, 2019EX2GSOU EXTENSION 2 GRANTED—
Jul 19, 2019EXT2SOU EXTENSION 2 FILED—
Jul 19, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2019EX1GSOU EXTENSION 1 GRANTED—
Jan 22, 2019EXT1SOU EXTENSION 1 FILED—
Jan 22, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 24, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 29, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 29, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 9, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 20, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Apr 20, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 20, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 20, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 18, 2017DOCKASSIGNED TO EXAMINER—
Jul 28, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 27, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 24, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance